GC Corp. (KRX:005250)

GC Corp. Revenue

GC Corp. had revenue of 596.27B KRW in the quarter ending June 30, 2026, a decrease of -0.71%. This brings the company's total for the last twelve months to 2.49T, up 9.57% year-over-year. In the year 2025, GC Corp. had annual revenue of 2.45T with 11.19% growth. That makes GC Corp. the 5,220th largest company in the world by revenue and 220th in South Korea.

• Revenue (ttm): 2.49T
• Revenue Growth: +9.57%
• P/S Ratio: 0.17
• Revenue / Employee: 17.52B
• Employees: 142
• Market Cap: 419.42B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Manufacturing and Sales of Pharmaceuticals, Etc. 2.02T 73.0%
• Development and supply of medical services and systems 240.54B 8.7%
• Other 226.82B 8.2%
• Diagnosis and Analysis of Samples, Etc. 215.15B 7.8%
• Rental and Service Industry 64.14B 2.3%

By Geography

Chart

• South Korea 2.19T 79.2%
• Overseas 575.62B 20.8%

Fiscal year ended Dec 31, 2025 See the full GC Corp. breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.45T	246.62B	11.19%
Dec 31, 2024	2.20T	146.92B	7.14%
Dec 31, 2023	2.06T	-21.62B	-1.04%
Dec 31, 2022	2.08T	239.00B	12.99%
Dec 31, 2021	1.84T	121.23B	7.05%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 29, 2026

Data Sources Report a data error